Clicky

Friday, November 20, 2026
All public companies · Official EDGAR

AKTXAkari Therapeutics Plc

Nasdaq · CIK 0001541157
Filer categoryNon-accelerated filer<br>Smaller reporting company
Entity typeoperating
SIC2834 Pharmaceutical Preparations
FY end1231
XBRL facts419

Identity from submissions API

NameAkari Therapeutics Plc
CIK0001541157
TickersAKTX
ExchangesNasdaq
Entity typeoperating
CategoryNon-accelerated filer<br>Smaller reporting company
SIC2834 Pharmaceutical Preparations
EIN981034922
LEI—
Fiscal year end1231
State of incorporationX0 United Kingdom
Phone(929) 274-7510
Website—
Investor website—
Owner org03 Life Sciences
Flags—
Description—
Insider transactions (issuer)1
Insider transactions (owner)0

Former names

  • Celsus Therapeutics Plc. (2012-07-25T00:00:00.000Z → 2015-09-15T00:00:00.000Z)
  • Morria Biopharmaceuticals PLC (2012-04-13T00:00:00.000Z → 2013-06-20T00:00:00.000Z)
Business address
401 EAST JACKSON STREET
SUITE 3300
TAMPA
FL
33602
FL
Mailing address
401 EAST JACKSON STREET
SUITE 3300
TAMPA
FL
33602
FL

EDGAR has no company-logo API. Website field is shown when the filer provided one.

Financialist coverage

SEC filings

748 filing rows loaded from submissions recent.

FiledFormDocumentItemsAccessionFile no.FilmActSizeXBRLiXBRL
2026-11-19 4 4 0001493152-26-053314 6912
2026-11-13 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-001483 005-87614 261551206 34 14369
2026-11-12 8-K 8-K 2.02,9.01 0001493152-26-051486 001-36288 261548173 34 326563 1 1
2026-11-12 10-Q 10-Q 0001493152-26-051372 001-36288 261546604 34 7785812 1 1
2026-11-12 SCHEDULE 13G/A xslSCHEDULE_13G_X02/primary_doc.xml 0000927971-26-000112 005-87614 261543290 34 1569895
2026-10-30 S-8 S-8 0001493152-26-049453 333-299741 261508784 33 356390 1 1
2026-10-30 8-K 8-K 5.07,9.01 0001493152-26-049446 001-36288 261508627 34 251737 1 1
2026-10-16 4 4 0001493152-26-047458 13940
2026-10-16 4 4 0001493152-26-047457 13847
2026-10-16 4 4 0001493152-26-047456 22912
2026-10-16 4 4 0001493152-26-047455 22844
2026-10-16 4 4 0001493152-26-047454 15692
2026-10-16 4 4 0001493152-26-047453 13847
2026-10-14 4 4 0001493152-26-047058 6310
2026-10-14 3 3 0001493152-26-047057 15666
2026-10-01 DEF 14A DEF 14A 0001493152-26-045371 001-36288 261432256 34 1710358
2026-10-01 4 4 0001493152-26-045366 5706
2026-10-01 8-K 8-K 5.02,9.01 0001493152-26-045364 001-36288 261432091 34 289717 1 1
2026-08-19 4 4 0001493152-26-039246 5349
2026-08-13 8-K 8-K 2.02,9.01 0001493152-26-037736 001-36288 261273051 34 298636 1 1
2026-08-13 10-Q 10-Q 0001493152-26-037730 001-36288 261272992 34 7253126 1 1
2026-08-12 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000927971-26-000091 005-87614 261265961 34 1569703
2026-08-07 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0001952614-26-000004 005-87614 261255767 34 8429
2026-08-05 4 4 0001493152-26-036231 5347
2026-07-17 4 4 0001493152-26-033634 17365
2026-07-13 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002279 333-297257 261172450 33 1965
2026-07-10 S-3/A S-3/A 0001493152-26-032841 333-297257 261168911 33 427277
2026-07-08 S-3/A S-3/A 0001493152-26-032503 333-297257 261162558 33 448560
2026-07-07 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-002205 333-289962 261160685 33 1965
2026-07-02 8-K 8-K 5.07,9.01 0001493152-26-031972 001-36288 261153140 34 285373 1 1
2026-07-02 S-3 S-3 0001493152-26-031967 333-297257 261153081 33 1044355 1 1
2026-06-26 8-K 8-K 1.01,9.01 0001493152-26-030341 001-36288 261130472 34 303695 1 1
2026-06-26 S-1/A S-1/A 0001493152-26-030330 333-289962 261130258 33 570875
2026-06-25 4 4 0001493152-26-030210 14717
2026-06-25 4 4 0001493152-26-030207 8402
2026-06-08 SCHEDULE 13G xslSCHEDULE_13G_X02/primary_doc.xml 0000912282-26-000802 005-87614 261074307 34 14332
2026-06-04 DEF 14A DEF 14A 0001493152-26-027279 001-36288 261065456 34 5613682 1 1
2026-06-03 D xslFormDX01/primary_doc.xml 06b 0001493152-26-027117 021-586106 261061781 33 13757
2026-05-22 PRE 14A PRE 14A 0001493152-26-025051 001-36288 261014645 34 7603051 1 1
2026-05-22 8-K 8-K 1.01,3.02,9.01 0001493152-26-025037 001-36288 261014376 34 1163964 1 1
2026-05-21 RW RW 0001493152-26-024741 333-295729 261005946 NE 13801
2026-05-19 10-Q 10-Q 0001493152-26-024446 001-36288 261000044 34 6260365 1 1
2026-05-18 NT 10-Q NT 10-Q 0001493152-26-024230 001-36288 26994908 34 45843
2026-05-08 S-1 S-1 0001493152-26-022019 333-295729 26959634 33 1688834 1 1
2026-04-15 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-001192 333-292930 26865533 33 1977
2026-04-10 POS AM POS AM 0001493152-26-016154 333-292930 26855033 33 446561
2026-04-02 DRS filename1.htm 0001493152-26-014977 377-09211 26835531 33 812460
2026-03-31 F-6/A d12123390_f-6a.htm 0000919574-26-001972 333-185197 26817421 33 230892
2026-03-30 10-K 10-K 0001493152-26-013664 001-36288 26813844 34 14209305 1 1
2026-03-17 8-K 8-K 3.03,7.01,9.01 0001493152-26-010602 001-36288 26763294 34 301379 1 1
2026-03-16 4 4 0001493152-26-010304 24487
2026-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-008880 005-87614 26722344 34 15645
2026-03-04 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0001493152-26-008874 005-87614 26722233 34 10687
2026-03-04 SCHEDULE 13G/A xslSCHEDULE_13G_X01/primary_doc.xml 0001493152-26-008873 005-87614 26722229 34 7381
2026-03-02 8-K 8-K 5.07 0001493152-26-008570 001-36288 26708982 34 256437 1 1
2026-02-02 DEF 14A DEF 14A 0001493152-26-004754 001-36288 26590828 34 4395319
2026-01-29 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-26-000356 333-292930 26580320 33 1964
2026-01-27 UPLOAD filename1.pdf 0000000000-26-000815 333-292930 40256
2026-01-27 CORRESP filename1.htm 0001493152-26-003763 12673
2026-01-23 S-1 S-1 0001493152-26-003458 333-292930 26557738 33 31190403 1 1
2026-01-22 PRE 14A PRE 14A 0001493152-26-003252 001-36288 26553567 34 4279293
2025-12-18 4 4 0001493152-25-028422 25761
2025-12-18 4 4 0001493152-25-028421 25480
2025-12-18 4 4 0001493152-25-028420 24241
2025-12-18 4 4 0001493152-25-028419 9187
2025-12-18 4 4 0001493152-25-028418 25665
2025-12-18 4 4 0001493152-25-028417 14801
2025-12-18 4 4 0001493152-25-028416 24575
2025-12-17 8-K 8-K 1.01,1.02,3.02,7.01,9.01 0001493152-25-028075 001-36288 251577511 34 2053199 1 1
2025-12-17 424B5 424B5 0001493152-25-028073 333-289056 251577501 33 772449
2025-12-16 8-K 8-K 5.07,9.01 0001493152-25-027969 001-36288 251575795 34 274180 1 1
2025-12-08 8-K 8-K 7.01,9.01 0001493152-25-026533 001-36288 251554682 34 4918686 1 1
2025-12-05 424B3 424B3 0001493152-25-026387 333-291596 251553395 33 401615
2025-12-02 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-003483 333-291596 251544870 33 1939
2025-12-01 CORRESP filename1.htm 0001493152-25-025537 11767
2025-11-26 8-K 8-K 3.01 0001493152-25-025177 001-36288 251531221 34 254228 1 1
2025-11-17 DEF 14A DEF 14A 0001493152-25-023911 001-36288 251491744 34 1729355
2025-11-17 S-1 S-1 0001493152-25-023908 333-291596 251491688 33 832432 1 1
2025-11-13 10-Q 10-Q 0001493152-25-022390 001-36288 251479576 34 9065299 1 1
2025-11-07 PRE 14A PRE 14A 0001493152-25-021316 001-36288 251463553 34 1729691
2025-11-04 4 4 0001493152-25-020753 7174
2025-10-24 4 4 0001493152-25-019194 5334
2025-10-24 3 3 0001493152-25-019192 12615
2025-10-24 D xslFormDX01/primary_doc.xml 06b 0001493152-25-019187 021-561958 251414406 33 14115
2025-10-23 8-K 8-K 5.02,9.01 0001493152-25-019112 001-36288 251413612 34 367578 1 1
2025-10-16 8-K 8-K 1.01,3.02,9.01 0001493152-25-018269 001-36288 251396617 34 1336670 1 1
2025-10-16 424B5 424B5 0001493152-25-018268 333-289056 251396601 33 744520
2025-10-15 8-K 8-K 7.01,9.01 0001493152-25-018091 001-36288 251393518 34 280607 1 1
2025-09-29 8-K 8-K 8.01 0001493152-25-016039 001-36288 251357086 34 244869 1 1
2025-09-25 8-K 8-K 1.01,8.01,9.01 0001493152-25-014962 001-36288 251344522 34 304167 1 1
2025-08-29 S-1 S-1 0001641172-25-026052 333-289962 251282046 33 1131861 1 1
2025-08-29 8-K 8-K 1.01,3.02,5.02,9.01 0001641172-25-026032 001-36288 251281806 34 771839 1 1
2025-08-29 4 xslF345X05/ownership.xml 0001641172-25-026025 9699
2025-08-21 8-K 8-K 1.01,1.02,2.03,9.01 0001641172-25-025104 001-36288 251241500 34 290822 1 1
2025-08-19 8-K 8-K 7.01,9.01 0001641172-25-024732 001-36288 251229679 34 7721601 1 1
2025-08-13 10-Q 10-Q 0001641172-25-023569 001-36288 251212668 34 7578844 1 1
2025-07-31 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-002439 333-289056 251173508 33 1923
2025-07-30 CORRESP filename1.htm 0001641172-25-021570 12086
2025-07-30 UPLOAD filename1.pdf 0000000000-25-008047 333-289056 40297
2025-07-29 S-8 S-8 0001641172-25-021432 333-289057 251163117 33 386528 1 1
2025-07-29 S-3 S-3 0001641172-25-021425 333-289056 251163064 33 1010980 1 1
2025-07-01 8-K 8-K 5.02,5.07,9.01 0000950170-25-092350 001-36288 251097556 34 331046 1 1
2025-06-25 4 4 0000950170-25-089976 6835
2025-06-24 4 4 0000950170-25-089462 4871
2025-06-20 4 4 0000950170-25-088490 4871
2025-06-16 4 4 0000950170-25-086829 6732
2025-06-12 4 4 0000950170-25-085472 5069
2025-06-06 ARS ARS 0001641172-25-014026 001-36288 251030636 34 2712530
2025-06-06 DEF 14A formdef14a.htm 0001641172-25-014023 001-36288 251030567 34 6280987 1 1
2025-05-23 PRE 14A PRE 14A 0001641172-25-012305 001-36288 25983247 34 6277509 1 1
2025-05-15 8-K 8-K 2.02,9.01 0000950170-25-072046 001-36288 25949058 34 1268268 1 1
2025-05-14 EFFECT xslEFFECTX01/primary_doc.xml ,, 9999999995-25-001605 333-287012 25948284 33 1922
2025-05-14 10-Q 10-Q 0000950170-25-071563 001-36288 25946704 34 10672402 1 1
2025-05-14 424B3 424B3 0000950170-25-071556 333-287012 25946665 33 779167
2025-05-12 CORRESP filename1.htm 0000950170-25-069161 33252
2025-05-09 UPLOAD filename1.pdf 0000000000-25-004988 333-287012 40279
2025-05-06 S-3 S-3 0000950170-25-064642 333-287012 25918401 33 1123688
2025-04-29 4 4 0000950170-25-060298 12850
2025-04-16 8-K 8-K 2.02,9.01 0000950170-25-054484 001-36288 25841252 34 619934 1 1
2025-04-15 10-K 10-K 0000950170-25-054278 001-36288 25840003 34 19664809 1 1
2025-03-31 NT 10-K NT 10-K 0000950170-25-047872 001-36288 25794612 34 50579
2025-03-24 4 4 0000950170-25-043940 9163
2025-03-24 4 4 0000950170-25-043939 9168
2025-03-24 4 4 0000950170-25-043938 9988
2025-03-24 4 4 0000950170-25-043935 12359
2025-03-24 4 4 0000950170-25-043937 10823
2025-03-24 4 4 0000950170-25-043936 9979
2025-03-24 4 4 0000950170-25-043934 9411
2025-03-24 4 4 0000950170-25-043933 9444
2025-03-20 8-K 8-K 5.02,9.01 0000950170-25-042342 001-36288 25754633 34 410084 1 1
2025-03-10 4 4 0000950170-25-036488 21853
2025-03-10 4 4 0000950170-25-036487 22619
2025-03-10 4 4 0000950170-25-036486 21996
2025-03-10 4 4 0000950170-25-036485 20921
2025-03-10 4 4 0000950170-25-036482 20941
2025-03-10 4 4 0000950170-25-036483 9724
2025-03-03 8-K 8-K 1.01,3.02,9.01 0001193125-25-043544 001-36288 25694338 34 715486 1 1
2025-02-14 SCHEDULE 13G xslSCHEDULE_13G_X01/primary_doc.xml 0000950170-25-021396 005-87614 25630517 34 7821
2025-02-14 SCHEDULE 13D/A xslSCHEDULE_13D_X01/primary_doc.xml 0000950170-25-021393 005-87614 25630508 34 14873
2025-02-07 4/A 4/A 0000950170-25-016334 5513
2025-01-13 4 4 0000950170-25-004580 5031
2025-01-13 4 4 0000950170-25-004577 4997
2025-01-13 8-K 8-K 7.01 0000950170-25-004576 001-36288 25524859 34 15772967 1 1
2025-01-10 4 4 0000950170-25-004300 4987
2025-01-07 4 4 0000950170-25-002865 5066
2025-01-07 4 4 0000950170-25-002864 8061
2024-12-30 4 4 0000950170-24-141162 7589
2024-12-30 4 4 0000950170-24-141158 5045
2024-12-27 4 4 0000950170-24-140808 5045
2024-12-27 4 4 0000950170-24-140807 5806
2024-12-26 4 4 0000950170-24-140431 4989
2024-12-26 4 4 0000950170-24-140430 5806
2024-12-26 3 3 0000950170-24-140428 15547
2024-12-26 4 4 0000950170-24-140427 5806
2024-12-20 3 3 0000950170-24-139079 16173
2024-12-18 8-K 8-K 5.02 0000950170-24-137922 001-36288 241559653 34 270538 1 1
2024-12-16 8-K 8-K 5.02 0000950170-24-136674 001-36288 241552219 34 266670 1 1
2024-12-12 8-K 8-K 5.02 0000950170-24-135822 001-36288 241545265 34 265932 1 1
2024-12-06 SC 13D/A AMENDMENT NO. 1 TO SCHEDULE 13D 0001213900-24-106465 005-87614 241532180 34 51291
2024-12-03 4 4 0000950170-24-132936 10804
2024-12-03 4 4 0000950170-24-132929 9245
2024-11-22 3 3 0000950170-24-130246 24760
2024-11-22 3 3 0000950170-24-130245 22214
2024-11-22 3 3 0000950170-24-130241 23325
2024-11-19 10-Q 10-Q 0000950170-24-128727 001-36288 241476936 34 8540068 1 1
2024-11-18 4 4 0000950170-24-128190 6723
2024-11-15 NT 10-Q NT 10-Q 0000950170-24-127569 001-36288 241467766 34 40590
2024-11-14 8-K 8-K 1.01,2.01,3.01,3.02,5.02,7.01,9.01 0000950170-24-127107 001-36288 241463008 34 1690185 1 1
2024-11-08 8-K 8-K 5.07,7.01,9.01 0000950170-24-123703 001-36288 241438044 34 333184 1 1
2024-11-01 4 4 0000950170-24-120185 5704
2024-10-15 425 425 0000950170-24-114476 001-36288 241369550 34 28110
2024-10-11 EFFECT xslEFFECTX01/primary_doc.xml S-4,,2024-10-11 16:45:00 9999999995-24-003169 333-282127 241368904 33 1930
2024-10-11 424B3 424B3 0001193125-24-236783 333-282127 241368063 33 15017458
2024-10-09 CORRESP filename1.htm 0001193125-24-235258 8573
2024-10-09 S-4/A S-4/A 0001193125-24-235233 333-282127 241363053 33 30420749 1 1
2024-10-04 8-K 8-K 3.01 0000950170-24-112930 001-36288 241355244 34 276774 1 1
2024-10-02 4 4 0000950170-24-111796 5707
2024-09-30 CORRESP filename1.htm 0001193125-24-228382 18216
2024-09-30 S-4/A S-4/A 0001193125-24-228130 333-282127 241336593 33 28361575 1 1
2024-09-26 UPLOAD filename1.pdf 0000000000-24-010957 333-282127 44612
2024-09-18 4 4 0000950170-24-107828 21728
2024-09-18 3 3 0000950170-24-107826 18579
2024-09-18 8-K 8-K 5.02,8.01,9.01 0000950170-24-107824 001-36288 241307980 34 1850243 1 1
2024-09-16 424B5 424B5 0001193125-24-219588 333-281995 241301074 33 265609
2024-09-13 EFFECT xslEFFECTX01/primary_doc.xml S-3,,2024-09-13 16:05:00 9999999995-24-002847 333-281995 241299223 33 1930
2024-09-13 S-4 S-4 0001193125-24-218968 333-282127 241298800 33 28271355 1 1
2024-09-11 CORRESP filename1.htm 0001193125-24-217279 6908
2024-09-11 UPLOAD filename1.pdf 0000000000-24-010266 333-281995 40237
2024-09-06 S-3 S-3 0001193125-24-215261 333-281995 241285292 33 666767
2024-09-06 8-K 8-K 8.01,9.01 0000950170-24-104428 001-36288 241285178 34 18228855 1 1
2024-08-23 8-K/A 8-K/A 5.02 0000950170-24-100211 001-36288 241236690 34 265007 1 1
2024-08-19 10-Q 10-Q 0000950170-24-098576 001-36288 241221018 34 8284679 1 1
2024-08-19 8-K 8-K 2.02,9.01 0000950170-24-098535 001-36288 241220717 34 419875 1 1
2024-08-15 NT 10-Q NT 10-Q 0000950170-24-097575 001-36288 241212601 34 45928
2024-07-02 4 4 0000950170-24-080538 21482
2024-07-02 4 4 0000950170-24-080542 21778
2024-07-02 4 4 0000950170-24-080540 21495
2024-07-02 4 4 0000950170-24-080541 21442
2024-07-02 4 4 0000950170-24-080539 21545
2024-07-01 8-K 8-K 5.07 0000950170-24-079669 001-36288 241091043 34 307800 1 1
2024-06-20 SC 13D/A SC 13D/A 0001104659-24-073133 005-87614 241054067 34 58346
2024-06-18 SC 13D aktx_13d.htm 0000908834-24-000173 005-87614 241051966 34 73235
2024-06-07 SC 13D SCHEDULE 13D 0001213900-24-050884 005-87614 241030940 34 49724
2024-06-05 8-K 8-K 5.02,9.01 0000950170-24-069414 001-36288 241022808 34 332157 1 1
2024-06-04 4 4 0000950170-24-068771 23370
2024-06-04 4 4 0000950170-24-068770 24577
2024-06-04 425 425 0000950170-24-068729 001-36288 241018575 34 710106
2024-06-04 8-K 8-K 1.01,3.02,9.01 0000950170-24-068304 001-36288 241016112 34 1057984 1 1
2024-06-04 ARS ARS 0001104659-24-067915 001-36288 241015239 34 949900
2024-06-03 DEF 14A DEF 14A 0001104659-24-067797 001-36288 241013854 34 1473533
2024-05-16 8-K 8-K 2.02,9.01 0000950170-24-060806 001-36288 24953616 34 389827 1 1
2024-05-15 10-Q 10-Q 0000950170-24-060556 001-36288 24952101 34 6778302 1 1
2024-05-07 8-K 8-K 2.05,5.02 0000950170-24-054726 001-36288 24923075 34 279199 1 1
2024-05-03 4 4 0000950170-24-053000 5237
2024-05-01 425 425 0000950170-24-051410 001-36288 24904230 34 111817
2024-05-01 8-K 8-K 5.02,8.01,9.01 0000950170-24-051383 001-36288 24903955 34 359455 1 1
2024-04-30 4 4 0000950170-24-050854 5114
2024-04-11 8-K 8-K 3.01 0000950170-24-043519 001-36288 24837083 34 264225 1 1
2024-04-01 8-K 8-K 2.02,9.01 0000950170-24-038854 001-36288 24805443 34 365179 1 1
2024-03-29 10-K 10-K 0000950170-24-038661 001-36288 24804289 34 9882236 1 1
2024-03-11 425 425 0001104659-24-033088 001-36288 24739212 34 254821
2024-03-11 8-K FORM 8-K 1.01,3.02,9.01 0001104659-24-033087 001-36288 24739207 34 535429 1 1
2024-03-05 425 425 0001104659-24-031076 176152
2024-03-05 425 425 0001104659-24-030781 001-36288 24718396 34 5943047
2024-03-05 8-K FORM 8-K 1.01,7.01,9.01 0001104659-24-030777 001-36288 24718385 34 6413254 1 1
2024-01-09 D xslFormDX01/primary_doc.xml 06b 0000911420-24-000004 021-501992 24524194 33 12232
2024-01-04 SC 13D/A SC 13D/A 0001104659-24-001229 005-87614 24510816 34 58844
2024-01-02 3 3 0000950170-24-000450 7992
2024-01-02 3 3 0000950170-24-000446 4735
2024-01-02 3 3 0000950170-24-000440 29928
2024-01-02 3 3 0000950170-24-000433 19408
2024-01-02 3 3 0000950170-24-000416 27928
2024-01-02 3 3 0000950170-24-000407 27737
2024-01-02 3 3 0000950170-24-000405 30930
2024-01-02 8-K FORM 8-K 1.01,3.02,7.01,8.01,9.01 0001104659-24-000353 001-36288 24502883 34 272613 1 1
2023-12-01 6-K FORM 6-K 0001104659-23-122605 001-36288 231457557 34 26020
2023-11-16 6-K FORM 6-K 0001104659-23-118919 001-36288 231412450 34 22386
2023-10-27 424B3 424B3 0001104659-23-112177 333-275119 231355700 33 387929
2023-10-26 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2023-10-26 16:00:00 9999999995-23-003103 333-275119 231351797 33 1881
2023-10-25 CORRESP filename1.htm 0001104659-23-111290 7254
2023-10-24 UPLOAD filename1.pdf 0000000000-23-011603 40355
2023-10-23 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-110512,2023-10-23 9999999995-23-003062 333-267840 231341041 33 1894
2023-10-23 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-110511,2023-10-23 9999999995-23-003060 333-233048 231341036 33 1894
2023-10-20 SC 13D/A SC 13D/A 0001104659-23-110535 005-87614 231337644 34 61636
2023-10-20 POS AM POS AM 0001104659-23-110512 333-267840 231337420 33 567569
2023-10-20 POS AM POS AM 0001104659-23-110511 333-233048 231337412 33 917662
2023-10-20 F-3 FORM F-3 0001104659-23-110497 333-275119 231337389 33 518577
2023-10-19 D xslFormDX01/primary_doc.xml 06c 0001567619-23-007516 021-495231 231334917 33 11619
2023-10-12 S-8 FORM S-8 0001104659-23-108838 333-274954 231323163 33 247478
2023-09-29 6-K 6-K 0001410578-23-002132 001-36288 231291938 34 5253942 1 1
2023-09-21 6-K FORM 6-K 0001104659-23-102597 001-36288 231267764 34 449216
2023-09-05 6-K FORM 6-K 0001104659-23-098031 001-36288 231234260 34 19182
2023-08-18 6-K FROM 6-K 0001104659-23-093258 001-36288 231183786 34 21212
2023-08-17 F-6 POS d10790953_f-6pos.htm 0000919574-23-004884 333-185197 231182273 33 225600
2023-08-15 6-K FORM 6-K 0001104659-23-091710 001-36288 231173237 34 21282
2023-08-02 6-K FORM 6-K 0001104659-23-086592 001-36288 231133761 34 23351
2023-07-27 6-K FORM 6-K 0001104659-23-084545 001-36288 231115332 34 20735
2023-07-25 6-K FORM 6-K 0001104659-23-083655 001-36288 231106552 34 8538609
2023-07-19 6-K FORM 6-K 0001104659-23-082194 001-36288 231095599 34 26202
2023-07-13 6-K FORM 6-K 0001104659-23-080571 001-36288 231085785 34 27782
2023-07-11 6-K FORM 6-K 0001104659-23-079826 001-36288 231081247 34 31714
2023-07-07 6-K FORM 6-K 0001104659-23-079148 001-36288 231077130 34 417726
2023-07-06 6-K FORM 6-K 0001104659-23-078500 001-36288 231072169 34 22061
2023-07-05 6-K FORM 6-K 0001104659-23-077829 001-36288 231066729 34 24600
2023-06-30 6-K FORM 6-K 0001104659-23-077165 001-36288 231062178 34 10444
2023-06-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-066685,2023-06-06 9999999995-23-001639 333-267840 23997561 33 1905
2023-06-06 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-23-066683,2023-06-06 9999999995-23-001636 333-233048 23997559 33 1905
2023-06-06 6-K FORM 6-K 0001104659-23-068365 001-36288 23995002 34 1294979
2023-05-31 POS AM POS AM 0001104659-23-066685 333-267840 23981935 33 575186
2023-05-31 POS AM POS AM 0001104659-23-066683 333-233048 23981885 33 687707
2023-05-31 S-8 FORM S-8 0001104659-23-066644 333-272301 23981566 33 124036
2023-05-22 6-K FORM 6-K 0001104659-23-062951 001-36288 23942511 34 6828019
2023-05-05 6-K FORM 6-K 0001104659-23-056311 001-36288 23891330 34 9869
2023-05-03 6-K FORM 6-K 0001104659-23-055556 001-36288 23885155 34 10852
2023-05-01 6-K FORM 6-K 0001104659-23-053561 001-36288 23870134 34 58439
2023-05-01 20-F 20-F 0001410578-23-000848 001-36288 23869094 34 9445780 1 1
2023-04-25 6-K FORM 6-K 0001104659-23-049637 001-36288 23845156 34 20510
2023-04-14 SC 13D/A SC 13D/A 0001104659-23-045574 005-87614 23821183 34 66559
2023-03-31 6-K FORM 6-K 0001104659-23-039826 001-36288 23784127 34 288201
2023-03-31 424B5 424B5 0001104659-23-039822 333-251673 23784103 33 890927
2023-03-29 6-K FORM 6-K 0001104659-23-038050 001-36288 23771976 34 21312
2023-03-28 6-K FORM 6-K 0001104659-23-037449 001-36288 23766382 34 284073
2023-03-13 6-K FORM 6-K 0001104659-23-031570 001-36288 23725896 34 9568
2023-02-21 6-K FORM 6-K 0001104659-23-023555 001-36288 23645360 34 26023
2023-02-15 6-K FORM 6-K 0001104659-23-022411 001-36288 23635771 34 6195482
2023-02-15 6-K FORM 6-K 0001104659-23-022221 001-36288 23633661 34 32285
2023-02-14 SC 13G/A AMENDMENT NO. 4 TO SCHEDULE 13G 0001213900-23-011501 005-87614 23628759 34 47645
2023-02-13 6-K FORM 6-K 0001104659-23-019053 001-36288 23614810 34 31643
2022-11-10 6-K FORM 6-K 0001104659-22-117213 001-36288 221378049 34 21420
2022-11-09 424B3 424B3 0001104659-22-116479 333-267840 221372699 33 450353
2022-11-08 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2022-11-08 16:00:00 9999999995-22-003234 333-267840 221370496 33 1893
2022-11-08 6-K FORM 6-K 0001104659-22-115968 001-36288 221369457 34 24614
2022-11-07 CORRESP filename1.htm 0001104659-22-115402 7817
2022-11-04 F-1/A FORM F-1/A 0001104659-22-114953 333-267840 221362968 33 558352
2022-10-28 6-K FORM 6-K 0001104659-22-112487 001-36288 221342457 34 22877
2022-10-19 UPLOAD filename1.pdf 0000000000-22-011483 40376
2022-10-12 F-1 FORM F-1 0001104659-22-108100 333-267840 221307145 33 1108499
2022-09-27 6-K 6-K 0001410578-22-002815 001-36288 221271479 34 5797025 1 1
2022-09-27 D xslFormDX01/primary_doc.xml 06b 0001104659-22-103309 021-460011 221271258 33 15110
2022-09-14 424B5 424B5 0001104659-22-099945 333-251673 221242495 33 1022084
2022-09-14 6-K FORM 6-K 0001104659-22-099940 001-36288 221242458 34 559179
2022-08-01 6-K FORM 6-K 0001104659-22-084758 001-36288 221125579 34 19218
2022-07-29 6-K FORM 6-K 0001104659-22-084312 001-36288 221121672 34 36336
2022-07-20 6-K FORM 6-K 0001104659-22-081197 001-36288 221094680 34 422325
2022-07-08 6-K FORM 6-K 0001104659-22-078136 001-36288 221072580 34 25612
2022-07-05 6-K FORM 6-K 0001104659-22-077439 001-36288 221066425 34 9658
2022-06-16 6-K FORM 6-K 0001104659-22-071571 001-36288 221019064 34 33576
2022-06-07 6-K FORM 6-K 0001104659-22-068646 001-36288 22999342 34 1146130
2022-05-20 6-K FORM 6-K 0001104659-22-063398 001-36288 22948041 34 22108
2022-05-17 6-K FORM 6-K 0001104659-22-061960 001-36288 22934972 34 112573
2022-05-16 20-F 20-F 0001410578-22-001546 001-36288 22925181 34 8724428 1 1
2022-05-11 6-K FORM 6-K 0001104659-22-058589 001-36288 22912219 34 30168
2022-05-09 6-K FORM 6-K 0001104659-22-057602 001-36288 22905872 34 30868
2022-04-29 NT 20-F NT 20-F 0001104659-22-053656 001-36288 22876282 34 22248
2022-03-10 424B5 424B5 0001104659-22-032164 333-251673 22727242 33 1044221
2022-03-10 6-K FORM 6-K 0001104659-22-032163 001-36288 22727227 34 418929
2022-03-04 6-K FORM 6-K 0001104659-22-030653 001-36288 22714955 34 35932
2022-02-28 6-K FORM 6-K 0001104659-22-028173 001-36288 22691412 34 29139
2022-02-14 SC 13G/A AMENDMENT NO. 3 TO SCHEDULE 13G 0001213900-22-007217 005-87614 22625374 34 47322
2022-01-26 6-K FORM 6-K 0001104659-22-007840 001-36288 22558379 34 24401
2022-01-19 6-K FORM 6-K 0001104659-22-005467 001-36288 22539142 34 22700
2022-01-14 SC 13D/A SC 13D/A 0001104659-22-004427 005-87614 22532083 34 67491
2022-01-07 F-6EF d9126416_f6-ef.htm 0000919574-22-000153 333-262049 22518228 33 219244
2022-01-04 424B5 424B5 0001104659-22-000597 333-251673 22503926 33 1042320
2022-01-04 6-K FORM 6-K 0001104659-22-000595 001-36288 22503923 34 448847
2021-12-21 6-K FORM 6-K 0001104659-21-152206 001-36288 211509811 34 4741538
2021-12-03 6-K FORM 6-K 0001104659-21-146368 001-36288 211470410 34 499859
2021-12-01 6-K FORM 6-K 0001104659-21-145535 001-36288 211463905 34 28017
2021-10-25 6-K FORM 6-K 0001104659-21-129538 001-36288 211344658 34 28888
2021-10-18 SC 13D/A SC 13D/A 0001104659-21-127232 005-87614 211328833 34 65962
2021-10-01 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-121279,2021-10-01 9999999995-21-003736 333-239923 211300885 33 1906
2021-10-01 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-121277,2021-10-01 9999999995-21-003734 333-234219 211300881 33 1906
2021-10-01 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-121280,2021-10-01 9999999995-21-003733 333-233048 211300879 33 1906
2021-10-01 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-121273,2021-10-01 9999999995-21-003732 333-227752 211300872 33 1906
2021-09-30 POS AM POS AM 0001104659-21-121280 333-233048 211295699 33 757079
2021-09-30 POS AM POS AM 0001104659-21-121279 333-239923 211295687 33 559040
2021-09-30 POS AM POS AM 0001104659-21-121277 333-234219 211295683 33 559040
2021-09-30 POS AM POS AM 0001104659-21-121273 333-227752 211295672 33 559040
2021-09-22 6-K FORM 6-K 0001104659-21-118339 001-36288 211270041 34 4237407 1
2021-08-31 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2021-08-31 16:30:00 9999999995-21-003368 333-258918 211228703 33 1893
2021-08-30 CORRESP filename1.htm 0001104659-21-111097 8834
2021-08-30 F-3/A F-3/A 0001104659-21-110671 333-258918 211220610 33 679467
2021-08-23 UPLOAD filename1.pdf 0000000000-21-010317 40247
2021-08-19 F-3 FORM F-3 0001104659-21-107461 333-258918 211188257 33 771768
2021-07-22 D xslFormDX01/primary_doc.xml 06b 0001104659-21-094969 021-407386 211108288 33 14432
2021-07-20 6-K FORM 6-K 0001104659-21-094037 001-36288 211101937 34 350979
2021-07-07 6-K FORM 6-K 0001104659-21-089778 001-36288 211077573 34 24147
2021-07-02 6-K FORM 6-K 0001104659-21-088355 001-36288 211067211 34 10708
2021-06-29 6-K FORM 6-K 0001104659-21-086886 001-36288 211058847 34 427441
2021-06-07 6-K FORM 6-K 0001104659-21-077796 001-36288 211000521 34 1283818
2021-04-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-056667,2021-04-30 9999999995-21-001645 333-233048 21881060 33 1905
2021-04-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-055821,2021-04-30 9999999995-21-001663 333-239923 21881045 33 1905
2021-04-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-055818,2021-04-30 9999999995-21-001639 333-227752 21881042 33 1905
2021-04-30 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-21-055819,2021-04-30 9999999995-21-001646 333-234219 21881040 33 1905
2021-04-28 POS AM POS AM 0001104659-21-056667 333-233048 21865761 33 845572
2021-04-28 6-K FORM 6-K 0001104659-21-056613 001-36288 21865086 34 23986
2021-04-28 POS AM POS AM 0001104659-21-055821 333-239923 21860985 33 577498
2021-04-28 POS AM POS AM 0001104659-21-055819 333-234219 21860984 33 577494
2021-04-28 POS AM POS AM 0001104659-21-055818 333-227752 21860981 33 577505
2021-04-21 6-K FORM 6-K 0001104659-21-052681 001-36288 21839062 34 97118
2021-04-21 20-F FORM 20-F 0001104659-21-052672 001-36288 21839039 34 31155785 1
2021-04-12 6-K FORM 6-K 0001104659-21-049365 001-36288 21821170 34 23492
2021-03-04 6-K FORM 6-K 0001104659-21-032207 001-36288 21715366 34 25637
2021-02-25 6-K FORM 6-K 0001104659-21-028270 001-36288 21680842 34 28521
2021-02-16 SC 13G/A AMENDMENT NO. 2 TO SCHEDULE 13G 0001213900-21-009267 005-87614 21632835 34 46657
2021-02-02 6-K FORM 6-K 0001104659-21-010336 001-36288 21578003 34 29679
2020-12-31 EFFECT xslEFFECTX01/primary_doc.xml F-3,,2020-12-31 16:00:00 9999999995-21-000013 333-251673 21500016 33 1892
2020-12-30 CORRESP filename1.htm 0001104659-20-140610 8024
2020-12-30 UPLOAD filename1.pdf 0000000000-20-012578 40410
2020-12-23 F-3 FORM F-3 0001104659-20-139239 333-251673 201413587 33 1663999
2020-12-11 6-K FORM 6-K 0001104659-20-134787 001-36288 201383783 34 593490
2020-12-11 6-K FORM 6-K 0001104659-20-134786 001-36288 201383777 34 33567
2020-12-09 6-K FORM 6-K 0001104659-20-133649 001-36288 201378001 34 11979
2020-12-03 6-K FORM 6-K 0001104659-20-132025 001-36288 201367363 34 32016
2020-11-16 6-K FORM 6-K 0001104659-20-125512 001-36288 201314224 34 1365890
2020-10-06 6-K FORM 6-K 0001104659-20-112454 001-36288 201225693 34 27099
2020-10-01 6-K FORM 6-K 0001104659-20-110761 001-36288 201214664 34 28338
2020-09-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-20-104500,2020-09-18 9999999995-20-002500 333-239923 201186261 33 1906
2020-09-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-20-104499,2020-09-18 9999999995-20-002499 333-234219 201186260 33 1906
2020-09-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-20-105362,2020-09-18 9999999995-20-002498 333-233048 201186249 33 1906
2020-09-18 EFFECT xslEFFECTX01/primary_doc.xml POS AM,0001104659-20-104498,2020-09-18 9999999995-20-002497 333-227752 201185860 33 1906
2020-09-16 POS AM POS AM 0001104659-20-105362 333-233048 201177138 33 841880
2020-09-14 POS AM POS AM 0001104659-20-104500 333-239923 201171847 33 592043
2020-09-14 POS AM POS AM 0001104659-20-104499 333-234219 201171845 33 592043
2020-09-14 POS AM POS AM 0001104659-20-104498 333-227752 201171844 33 592043
2020-09-01 6-K FORM 6-K 0001104659-20-101145 001-36288 201153495 34 4473314 1
2020-08-31 6-K FORM 6-K 0001104659-20-100473 001-36288 201149875 34 41650
2020-08-12 6-K FORM 6-K 0001104659-20-093589 001-36288 201094382 34 34642
2020-08-11 SC 13G/A SC 13G/A - AMENDMENT NO. 1 0001193125-20-216306 005-87614 201092613 34 43216
2020-07-28 424B3 424B3 0001104659-20-087337 333-239923 201054067 33 451392
2020-07-27 EFFECT xslEFFECTX01/primary_doc.xml F-1,,2020-07-27 16:00:00 9999999995-20-001932 333-239923 201051650 33 1893
2020-07-24 UPLOAD filename1.pdf 0000000000-20-006756 40432
2020-07-24 CORRESP filename1.htm 0001104659-20-086242 8673
2020-07-17 F-1 FORM F-1 0001104659-20-084530 333-239923 201034032 33 620504
2020-07-02 SC 13G SC 13G 0001193125-20-185791 005-87614 201007118 34 218170
2020-07-01 6-K FORM 6-K 0001104659-20-079457 001-36288 201004272 34 300298
2020-07-01 6-K FORM 6-K 0001104659-20-079454 001-36288 201004265 34 156691
2020-06-01 6-K FORM 6-K 0001104659-20-068030 001-36288 20931098 34 1079717
2020-05-29 6-K FORM 6-K 0001104659-20-067346 001-36288 20924031 34 451158
2020-05-21 6-K FORM 6-K 0001104659-20-064768 001-36288 20902076 34 24095

Latest XBRL company facts

One latest value per concept from companyfacts (419 concepts). Full history stays in the JSON.

TaxonomyTagLabelUnitValueStartEndFYFPFormFiledAccn
dei EntityCommonStockSharesOutstanding Entity Common Stock, Shares Outstanding shares 186.09B 2026-11-12 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
dei EntityPublicFloat Entity Public Float USD 15.00M 2025-06-30 2025 FY 10-K 2026-03-30 0001493152-26-013664
ecd NonPeoNeoAvgCompActuallyPaidAmt NonPeoNeoAvgCompActuallyPaidAmt USD 277,512 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001493152-26-027279
ecd NonPeoNeoAvgTotalCompAmt NonPeoNeoAvgTotalCompAmt USD 369,695 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001493152-26-027279
ecd TotalShareholderRtnAmt TotalShareholderRtnAmt USD 2.94 2025-01-01 2025-12-31 DEF 14A 2026-06-04 0001493152-26-027279
ffd NetFeeAmt NetFeeAmt USD 1,378.08 2026-10-30 S-8 2026-10-30 0001493152-26-049453
ffd TtlFeeAmt TtlFeeAmt USD 1,378.08 2026-10-30 S-8 2026-10-30 0001493152-26-049453
ffd TtlOfferingAmt TtlOfferingAmt USD 15.84M 2026-10-30 S-8 2026-10-30 0001493152-26-049453
ffd TtlOffsetAmt TtlOffsetAmt USD 0 2026-10-30 S-8 2026-10-30 0001493152-26-049453
ffd TtlPrevslyPdAmt TtlPrevslyPdAmt USD 0 2026-07-02 S-3 2026-07-02 0001493152-26-031967
us-gaap AccountsPayableCurrent Accounts Payable, Current USD 9.05M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AccountsPayableOtherCurrent Accounts Payable, Other, Current USD 331,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap AccountsPayableRelatedPartiesCurrent Accounts Payable, Related Parties, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-23 0001144204-16-089697
us-gaap AccountsPayableTradeCurrent Accounts Payable, Trade, Current USD 629,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap AccountsReceivableGrossCurrent Accounts Receivable, before Allowance for Credit Loss, Current USD 6,000 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap AccountsReceivableRelatedPartiesCurrent Accounts Receivable, Related Parties, Current USD 10,502 2016-06-30 2016 Q2 6-K 2017-04-14 0001144204-17-020551
us-gaap AccruedEmployeeBenefitsCurrent Accrued Employee Benefits, Current USD 618,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AccruedLiabilitiesCurrent Accrued Liabilities, Current USD 3.79M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AccruedProfessionalFeesCurrent Accrued Professional Fees, Current USD 1.07M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment USD 599,784 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap AccumulatedOtherComprehensiveIncomeLossNetOfTax Accumulated Other Comprehensive Income (Loss), Net of Tax USD -614,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AdditionalCollateralAggregateFairValue Additional Collateral, Aggregate Fair Value USD 191,800 2024-11-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AdditionalPaidInCapital Additional Paid in Capital USD 247.43M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AdditionalPaidInCapitalCommonStock Additional Paid in Capital, Common Stock USD 215.51M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap AdjustmentForAmortization Amortization USD 1,850 2023-01-01 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap AdjustmentsRelatedToTaxWithholdingForShareBasedCompensation Share-based Payment Arrangement, Decrease for Tax Withholding Obligation USD 193,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap AdjustmentsToAdditionalPaidInCapitalConvertibleDebtWithConversionFeature Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD 250,000 2012-01-01 2012-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap AdjustmentsToAdditionalPaidInCapitalOther Adjustments to Additional Paid in Capital, Other USD 3.99M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD 537,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition USD 26,000 2024-07-01 2024-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022390
us-gaap AdjustmentsToAdditionalPaidInCapitalWarrantIssued Adjustments to Additional Paid in Capital, Warrant Issued USD 1.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap AdjustmentsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities Adjustments to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities USD -2.77M 2022-01-01 2022-06-30 2022 Q2 6-K 2022-09-27 0001410578-22-002815
us-gaap AllocatedShareBasedCompensationExpense Share-based Payment Arrangement, Expense USD 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AmortizationOfAcquisitionCosts Amortization of Acquisition Costs USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap AmortizationOfDebtDiscountPremium Amortization of Debt Discount (Premium) USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap AmortizationOfFinancingCosts Amortization of Debt Issuance Costs USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap AmortizationOfFinancingCostsAndDiscounts Amortization of Debt Issuance Costs and Discounts USD 500,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount shares 401.02B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AssetImpairmentCharges Asset Impairment Charges USD 5.18M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap Assets Assets USD 36.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AssetsCurrent Assets, Current USD 6.28M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap AssetsFairValueDisclosure Assets, Fair Value Disclosure USD 0 2020-12-31 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap BridgeLoan Bridge Loan GBP 200,000 2005-12-31 2012 FY 20-F/A 2013-04-19 0001144204-13-022773
us-gaap BusinessAcquisitionCostOfAcquiredEntityTransactionCosts Business Acquisition, Transaction Costs USD 3.20M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap BusinessAcquisitionEquityInterestsIssuedOrIssuableNumberOfSharesIssued Business Acquisition, Equity Interest Issued or Issuable, Number of Shares shares 188,303 2015-09-01 2015-09-18 2015 FY 10-K 2016-03-23 0001144204-16-089697
us-gaap BusinessAcquisitionPercentageOfVotingInterestsAcquired Business Acquisition, Percentage of Voting Interests Acquired pure 0.917 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap BusinessCombinationAcquisitionRelatedCosts Business Combination, Acquisition Related Costs USD 3.27M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap BusinessCombinationConsiderationTransferred1 Business Combination, Consideration Transferred USD 20.34M 2015-09-01 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCashAndEquivalents Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Cash and Equivalents USD 1.41M 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets USD 1.67M 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentLiabilitiesOther Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Liabilities, Other USD 368,670 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap BusinessCombinationRecognizedIdentifiableAssetsAcquiredGoodwillAndLiabilitiesAssumedNet Business Combination, Recognized Identifiable Assets Acquired, Goodwill, and Liabilities Assumed, Net USD 20.34M 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap CapitalExpendituresIncurredButNotYetPaid Capital Expenditures Incurred but Not yet Paid USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap Cash Cash USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CashAcquiredFromAcquisition Cash Acquired from Acquisition USD 382,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap CashAndCashEquivalentsAtCarryingValue Cash and Cash Equivalents, at Carrying Value USD 5.74M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CashAndCashEquivalentsPeriodIncreaseDecrease Cash and Cash Equivalents, Period Increase (Decrease) USD -13.04M 2018-01-01 2018-06-30 2018 Q2 6-K 2018-09-27 0001144204-18-050995
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 5.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Excluding Exchange Rate Effect USD -139,902 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect USD 540,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CashEquivalentsAtCarryingValue Cash Equivalents, at Carrying Value USD 0 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap CashFDICInsuredAmount Cash, FDIC Insured Amount USD 250,000 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap ClassOfWarrantOrRightExercisePriceOfWarrantsOrRights1 Class of Warrant or Right, Exercise Price of Warrants or Rights USD/shares 0.189 2015-09-18 2016 FY 20-F 2017-03-31 0001144204-17-018167
us-gaap ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights Class of Warrant or Right, Number of Securities Called by Warrants or Rights shares 1.03B 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ClassOfWarrantOrRightOutstanding Class of Warrant or Right, Outstanding shares 6.12M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockDiscountOnShares Common Stock, Discount on Shares USD 1.03B 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockParOrStatedValuePerShare Common Stock, Par or Stated Value Per Share USD/shares 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockSharesAuthorized Common Stock, Shares Authorized shares 4.37T 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockSharesIssued Common Stock, Shares, Issued shares 182.81B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockSharesOutstanding Common Stock, Shares, Outstanding shares 182.81B 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap CommonStockSharesSubscriptions Common Stock, Value, Subscriptions USD 0 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap CommonStockValue Common Stock, Value, Issued USD 1,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ComprehensiveIncomeNetOfTax Comprehensive Income (Loss), Net of Tax, Attributable to Parent USD -23.94M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ConvertibleDebt Convertible Debt USD 673,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ConvertibleNotesPayableCurrent Convertible Notes Payable, Current USD 0 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap CurrentFederalTaxExpenseBenefit Current Federal Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap CurrentForeignTaxExpenseBenefit Current Foreign Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap CurrentIncomeTaxExpenseBenefit Current Income Tax Expense (Benefit) USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap CurrentStateAndLocalTaxExpenseBenefit Current State and Local Tax Expense (Benefit) USD -42,000 2022-01-01 2022-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DebtConversionConvertedInstrumentSharesIssued1 Debt Conversion, Converted Instrument, Shares Issued shares 50,273 2022-09-01 2022-09-30 8-K 2024-09-06 0000950170-24-104428
us-gaap DebtConversionOriginalDebtAmount1 Debt Conversion, Original Debt, Amount USD 1.60M 2025-12-17 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DebtInstrumentConvertibleBeneficialConversionFeature Debt Instrument, Convertible, Beneficial Conversion Feature USD 250,000 2012-01-01 2012-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap DebtInstrumentConvertibleConversionPrice1 Debt Instrument, Convertible, Conversion Price USD/shares 1.59 2024-10-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DebtInstrumentFaceAmount Debt Instrument, Face Amount USD 1.10M 2012-12-31 2012 FY 20-F/A 2013-04-19 0001144204-13-022773
us-gaap DebtInstrumentIncreaseAccruedInterest Debt Instrument, Increase, Accrued Interest USD 26,830 2023-04-28 8-K 2024-09-06 0000950170-24-104428
us-gaap DebtInstrumentInterestRateStatedPercentage Debt Instrument, Interest Rate, Stated Percentage pure 0.05 2023-03-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DebtInstrumentIssuedPrincipal DebtInstrumentIssuedPrincipal USD 448,940 2023-04-28 8-K 2024-09-06 0000950170-24-104428
us-gaap DebtInstrumentUnamortizedDiscount Debt Instrument, Unamortized Discount USD 3.00M 2015-09-30 2017 Q2 6-K 2017-08-10 0001144204-17-042102
us-gaap DebtIssuanceCostsIncurredDuringNoncashOrPartialNoncashTransaction Debt Issuance Costs Incurred During Noncash or Partial Noncash Transaction USD 321,956 2020-01-01 2020-06-30 2020 Q2 6-K 2020-09-01 0001104659-20-101145
us-gaap DebtRelatedCommitmentFeesAndDebtIssuanceCosts Debt Related Commitment Fees and Debt Issuance Costs USD 0 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense Deferred Compensation Arrangement with Individual, Allocated Share-based Compensation Expense USD 100,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap DeferredCompensationArrangementWithIndividualRecordedLiability Deferred Compensation Arrangement with Individual, Recorded Liability USD 32,800 2024-08-14 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredFederalIncomeTaxExpenseBenefit Deferred Federal Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap DeferredFinanceCostsCurrentNet Debt Issuance Costs, Current, Net USD 278,000 2019-12-31 2019 FY 20-F 2020-03-31 0001104659-20-040722
us-gaap DeferredForeignIncomeTaxExpenseBenefit Deferred Foreign Income Tax Expense (Benefit) USD 0 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap DeferredIncomeTaxesAndTaxCredits Deferred Income Taxes and Tax Credits USD -1.09M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022390
us-gaap DeferredIncomeTaxExpenseBenefit Deferred Income Tax Expense (Benefit) USD -859,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap DeferredIncomeTaxLiabilities Deferred Tax Liabilities, Gross USD 7.06M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredIncomeTaxLiabilitiesNet Deferred Income Tax Liabilities, Net USD 6.09M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap DeferredOfferingCosts Deferred Offering Costs USD 321,956 2019-12-31 2019 FY 20-F 2020-03-31 0001104659-20-040722
us-gaap DeferredStateAndLocalIncomeTaxExpenseBenefit Deferred State and Local Income Tax Expense (Benefit) USD -1.06M 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsGoodwillAndIntangibleAssets Deferred Tax Assets, Goodwill and Intangible Assets USD 692,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsGross Deferred Tax Assets, Gross USD 63.46M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsInProcessResearchAndDevelopment Deferred Tax Assets, in Process Research and Development USD 1.02M 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsLiabilitiesNet Deferred Tax Assets, Net USD 0 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsNet Deferred Tax Assets, Net of Valuation Allowance USD 106,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsOperatingLossCarryforwards Deferred Tax Assets, Operating Loss Carryforwards USD 61.19M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsDomestic Deferred Tax Assets, Operating Loss Carryforwards, Domestic USD 2.24M 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsForeign Deferred Tax Assets, Operating Loss Carryforwards, Foreign USD 8.89M 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsOperatingLossCarryforwardsStateAndLocal Deferred Tax Assets, Operating Loss Carryforwards, State and Local USD 839,000 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsOther Deferred Tax Assets, Other USD 7,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsTaxCreditCarryforwards Deferred Tax Assets, Tax Credit Carryforwards USD 331,000 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap DeferredTaxAssetsTaxCreditCarryforwardsForeign Deferred Tax Assets, Tax Credit Carryforwards, Foreign USD 375,000 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsOther Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Other USD 0 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost USD 1.06M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities USD 171,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxAssetsValuationAllowance Deferred Tax Assets, Valuation Allowance USD 63.36M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxLiabilities Deferred Tax Liabilities, Net USD 6.95M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxLiabilitiesDeferredExpenseCapitalizedResearchAndDevelopmentCosts Deferred Tax Liabilities, Deferred Expense, Capitalized Research and Development Costs USD 6.95M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxLiabilitiesOther Deferred Tax Liabilities, Other USD 106,000 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DeferredTaxLiabilitiesOtherFiniteLivedAssets Deferred Tax Liabilities, Other Finite-Lived Assets USD 8.00M 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DepositAssets Deposit Assets USD 142,079 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067423
us-gaap Depreciation Depreciation USD 53,585 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap DepreciationDepletionAndAmortization Depreciation, Depletion and Amortization USD 14,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DerivativeAssetsCurrent Derivative Asset, Current USD 0 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap DerivativeFairValueOfDerivativeLiability Derivative Liability, Fair Value, Gross Liability USD 0 2018-06-30 2018 Q2 6-K 2018-09-27 0001144204-18-050995
us-gaap DerivativeGainLossOnDerivativeNet Derivative, Gain (Loss) on Derivative, Net USD -230,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap DerivativeLiabilities Derivative Liability USD 230,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap DerivativeLiabilitiesCurrent Derivative Liability, Current USD 1.85M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap DerivativeLiabilitiesNoncurrent Derivative Liability, Noncurrent USD 230,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap DueToOfficersOrStockholdersCurrent Due to Officers or Stockholders, Current USD 0 2015-12-31 2015 FY 10-K 2016-03-23 0001144204-16-089697
us-gaap DueToOtherRelatedPartiesCurrentAndNoncurrent Due to Other Related Parties USD 0 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap EarningsPerShareBasic Earnings Per Share, Basic USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap EarningsPerShareBasicAndDiluted Earnings Per Share, Basic and Diluted USD/shares 0 2021-01-01 2021-06-30 2021 Q2 6-K 2021-09-22 0001104659-21-118339
us-gaap EarningsPerShareDiluted Earnings Per Share, Diluted USD/shares 0 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap EffectiveIncomeTaxRateContinuingOperations Effective Income Tax Rate Reconciliation, Percent pure 0.055 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent pure 0.25 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent pure 0.977 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent pure -0.004 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent pure -0.01 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitAmount Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Amount USD 685,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent pure 0.078 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap EffectiveIncomeTaxRateReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Percent pure 0.145 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap EffectOfExchangeRateOnCashAndCashEquivalentsContinuingOperations Effect of Exchange Rate on Cash and Cash Equivalents, Continuing Operations USD -140,732 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents USD 1,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap EmployeeRelatedLiabilitiesCurrent Employee-related Liabilities, Current USD 4,000 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount USD 3 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount USD 30,000 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap EquityClassifiedWrittenCallOptionModificationEquityIssuanceIncreaseDecreaseInEquityAmount EquityClassifiedWrittenCallOptionModificationEquityIssuanceIncreaseDecreaseInEquityAmount USD 2.64M 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap EquityIssuancePerShareAmount Development Stage Entities, Equity Issuance, Per Share Amount (Deprecated 2015-01-31) USD 2 2015-01-01 2015-03-31 2015 Q1 10-Q 2015-05-12 0001144204-15-029638
us-gaap EscrowDeposit Escrow Deposit USD 4.55M 2022-10-25 8-K 2024-09-06 0000950170-24-104428
us-gaap EscrowDepositDisbursementsRelatedToPropertyAcquisition1 Escrow Deposit Disbursements Related to Property Acquisition USD 4.55M 2022-12-29 8-K 2024-09-06 0000950170-24-104428
us-gaap FairValueAdjustmentOfWarrants Fair Value Adjustment of Warrants USD 82,100 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap FairValueAssumptionsExpectedDividendRate Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) pure 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap FairValueAssumptionsExpectedVolatilityRate Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) pure 0.841 2013-01-01 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap FairValueAssumptionsRiskFreeInterestRate Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) pure 0.002 2013-01-01 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap FairValueLiabilitiesMeasuredOnRecurringBasisChangeInUnrealizedGainLoss Fair Value, Liability, Recurring Basis, Still Held, Unrealized Gain (Loss) USD -27,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInEarnings1 Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Earnings USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityIssues Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Issuances USD 14.80M 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038661
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityPeriodIncreaseDecrease Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Period Increase (Decrease) USD 54,000 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements USD -28,000 2013-01-01 2013-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilityTransfersNet Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Transfers, Net USD 3 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value USD 1.07M 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap FairValueNetDerivativeAssetLiabilityMeasuredOnRecurringBasisWithUnobservableInputs Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis with Unobservable Inputs USD 27.17M 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067423
us-gaap FinancialGuaranteeInsuranceContractsPremiumReceivable Financial Guarantee Insurance Contracts, Premium Receivable USD 631,993 2023-11-01 8-K 2024-09-06 0000950170-24-104428
us-gaap FinancialGuaranteeInsuranceContractsPremiumReceivedOverContractPeriodPremiumReceivableWeightedAverageRiskFreeDiscountRate Financial Guarantee Insurance Contracts, Premium Received over Contract Period, Premium Receivable, Weighted Average Risk Free Discount Rate pure 0.1 2023-11-01 2023-11-30 8-K 2024-09-06 0000950170-24-104428
us-gaap FinancialLiabilitiesFairValueDisclosure Financial Liabilities Fair Value Disclosure USD 725,000 2024-09-30 2024 Q3 10-Q 2024-11-19 0000950170-24-128727
us-gaap FinancingInterestExpense Financing Interest Expense USD 23.00M 2015-01-01 2015-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap ForeignCurrencyTransactionGainBeforeTax Foreign Currency Transaction Gain, before Tax USD 356,954 2016-01-01 2016-06-30 2016 Q2 6-K 2017-04-14 0001144204-17-020551
us-gaap ForeignCurrencyTransactionGainLossBeforeTax Foreign Currency Transaction Gain (Loss), before Tax USD -201,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ForeignCurrencyTransactionGainLossRealized Foreign Currency Transaction Gain (Loss), Realized USD -70,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ForeignCurrencyTransactionGainLossUnrealized Foreign Currency Transaction Gain (Loss), Unrealized USD -255,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap ForeignCurrencyTransactionLossBeforeTax Foreign Currency Transaction Loss, before Tax USD 35,000 2013-01-01 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap GainLossOnDerivativeInstrumentsNetPretax Gain (Loss) on Derivative Instruments, Net, Pretax USD 230,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap GainLossOnSaleOfDerivatives Gain (Loss) on Sale of Derivatives USD 549,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap GainLossOnSaleOfPropertyPlantEquipment Gain (Loss) on Disposition of Property Plant Equipment USD -1,216 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap GainLossRelatedToLitigationSettlement Gain (Loss) Related to Litigation Settlement USD -2.70M 2017-01-01 2017-12-31 2020 Q2 6-K 2020-09-01 0001104659-20-101145
us-gaap GainsLossesOnExtinguishmentOfDebt Gain (Loss) on Extinguishment of Debt USD -967,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap GeneralAndAdministrativeExpense General and Administrative Expense USD 3.42M 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap Goodwill Goodwill USD 8.43M 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap GoodwillImpairmentLoss Goodwill, Impairment Loss USD 8.43M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap GoodwillPeriodIncreaseDecrease Goodwill, Period Increase (Decrease) USD 0 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap ImpairmentOfIntangibleAssetsExcludingGoodwill Impairment of Intangible Assets (Excluding Goodwill) USD 3.70M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic Income (Loss) from Continuing Operations before Income Taxes, Domestic USD -19.68M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest USD -24.96M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign Income (Loss) from Continuing Operations before Income Taxes, Foreign USD 1.38M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxCreditsAndAdjustments Income Tax Credits and Adjustments USD 1.10M 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022390
us-gaap IncomeTaxesPaid Income Taxes Paid USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncomeTaxesPaidNet Income Taxes Paid, Net USD 90,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncomeTaxExpenseBenefit Income Tax Expense (Benefit) USD -859,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Amount USD 7.43M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationChangeInEnactedTaxRate Effective Income Tax Rate Reconciliation, Change in Enacted Tax Rate, Amount USD 4 2022-01-01 2022-12-31 2023 FY 10-K 2024-03-29 0000950170-24-038661
us-gaap IncomeTaxReconciliationDispositionOfBusiness Effective Income Tax Rate Reconciliation, Disposition of Business, Amount USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap IncomeTaxReconciliationForeignIncomeTaxRateDifferential Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount USD 1,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount USD -4.95M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap IncomeTaxReconciliationNondeductibleExpense Effective Income Tax Rate Reconciliation, Nondeductible Expense, Amount USD 818,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount USD 1,000 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap IncomeTaxReconciliationOtherAdjustments Effective Income Tax Rate Reconciliation, Other Adjustments, Amount USD -4.16M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap IncomeTaxReconciliationOtherReconcilingItems Effective Income Tax Rate Reconciliation, Other Reconciling Items, Amount USD 178,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationPriorYearIncomeTaxes Effective Income Tax Rate Reconciliation, Prior Year Income Taxes, Amount USD -6.63M 2023-01-01 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap IncomeTaxReconciliationStateAndLocalIncomeTaxes Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount USD 949,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationTaxCredits Effective Income Tax Rate Reconciliation, Tax Credit, Amount USD 4.90M 2017-01-01 2017-12-31 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap IncomeTaxReconciliationTaxCreditsForeign Effective Income Tax Rate Reconciliation, Tax Credit, Foreign, Amount USD 1.29M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap IncomeTaxReconciliationTaxCreditsResearch Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount USD 2.32M 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap IncreaseDecreaseInAccountsPayable Increase (Decrease) in Accounts Payable USD -128,820 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncreaseDecreaseInAccountsPayableAndAccruedLiabilities Increase (Decrease) in Accounts Payable and Accrued Liabilities USD 1.41M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncreaseDecreaseInAccountsPayableTrade Increase (Decrease) in Accounts Payable, Trade USD -374,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap IncreaseDecreaseInAccountsReceivable Increase (Decrease) in Accounts Receivable USD 2.90M 2019-01-01 2019-09-30 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap IncreaseDecreaseInAccruedLiabilities Increase (Decrease) in Accrued Liabilities USD -746,541 2023-01-01 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap IncreaseDecreaseInDerivativeLiabilities Increase (Decrease) in Derivative Liabilities USD 200,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IncreaseDecreaseInOperatingLeaseLiability IncreaseDecreaseInOperatingLeaseLiability USD 164,281 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncreaseDecreaseInOtherAccountsPayable Increase (Decrease) in Other Accounts Payable USD -25,000 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap IncreaseDecreaseInOtherCurrentAssets Increase (Decrease) in Other Current Assets USD 86,979 2023-01-01 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap IncreaseDecreaseInOtherNoncurrentAssets Increase (Decrease) in Other Noncurrent Assets USD 1,936 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncreaseDecreaseInOtherNoncurrentLiabilities Increase (Decrease) in Other Noncurrent Liabilities USD -230,650 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncreaseDecreaseInOtherOperatingLiabilities Increase (Decrease) in Other Operating Liabilities USD 0 2020-01-01 2020-12-31 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets Increase (Decrease) in Prepaid Expense and Other Assets USD -895,591 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap IncreaseDecreaseInPrepaidExpense Increase (Decrease) in Prepaid Expense USD 164,484 2023-01-01 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap IncreaseDecreaseInPrepaidExpensesOther Increase (Decrease) in Prepaid Expenses, Other USD -192,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IntangibleAssetsNetExcludingGoodwill Intangible Assets, Net (Excluding Goodwill) USD 14,000 2023-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap InterestAndOtherIncome Interest and Other Income USD 3 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap InterestExpense Interest Expense USD 100,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap InterestExpenseDebt Interest Expense, Debt USD 3.00M 2015-01-01 2015-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap InterestExpenseNonoperating InterestExpenseNonoperating USD 226,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap InterestExpenseOther Interest Expense, Other USD 772,102 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap InterestPaid Interest Paid, Including Capitalized Interest, Operating and Investing Activities USD 0 2016-01-01 2016-06-30 2016 Q2 6-K 2017-04-14 0001144204-17-020551
us-gaap InterestPaidNet Interest Paid, Excluding Capitalized Interest, Operating Activities USD 59,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap InterestPayableCurrent Interest Payable, Current USD 0 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap InvestmentIncomeInterest Investment Income, Interest USD 1,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap IssuanceOfStockAndWarrantsForServicesOrClaims Issuance of Stock and Warrants for Services or Claims USD 27,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap Liabilities Liabilities USD 19.08M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap LiabilitiesAndStockholdersEquity Liabilities and Equity USD 36.58M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap LiabilitiesAssumed1 Liabilities Assumed USD 1.84M 2024-01-01 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap LiabilitiesCurrent Liabilities, Current USD 12.98M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap LiabilitiesFairValueAdjustment Liabilities, Fair Value Adjustment USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap LiabilitiesNoncurrent Liabilities, Noncurrent USD 0 2018-12-31 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap LitigationSettlementAmountAwardedToOtherParty Litigation Settlement, Amount Awarded to Other Party USD 100,000 2025-01-01 2025-09-30 2025 Q3 10-Q 2025-11-13 0001493152-25-022390
us-gaap LitigationSettlementExpense Litigation Settlement, Expense USD 0 2020-01-01 2020-12-31 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap NetCashProvidedByUsedInFinancingActivities Net Cash Provided by (Used in) Financing Activities USD 10.36M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NetCashProvidedByUsedInFinancingActivitiesContinuingOperations Net Cash Provided by (Used in) Financing Activities, Continuing Operations USD 0 2016-01-01 2016-06-30 2016 Q2 6-K 2017-04-14 0001144204-17-020551
us-gaap NetCashProvidedByUsedInInvestingActivities Net Cash Provided by (Used in) Investing Activities USD 382,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap NetCashProvidedByUsedInInvestingActivitiesContinuingOperations Net Cash Provided by (Used in) Investing Activities, Continuing Operations USD 9.99M 2017-01-01 2017-06-30 2017 Q2 6-K 2017-08-10 0001144204-17-042102
us-gaap NetCashProvidedByUsedInOperatingActivities Net Cash Provided by (Used in) Operating Activities USD -9.82M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NetCashProvidedByUsedInOperatingActivitiesContinuingOperations Net Cash Provided by (Used in) Operating Activities, Continuing Operations USD -13.87M 2017-01-01 2017-06-30 2017 Q2 6-K 2017-08-10 0001144204-17-042102
us-gaap NetIncomeLoss Net Income (Loss) Attributable to Parent USD -24.11M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NetIncomeLossAvailableToCommonStockholdersBasic Net Income (Loss) Available to Common Stockholders, Basic USD -9.65M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap NoncashOrPartNoncashAcquisitionDebtAssumed1 Noncash or Part Noncash Acquisition, Debt Assumed USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap NoncashOrPartNoncashAcquisitionFixedAssetsAcquired1 Noncash or Part Noncash Acquisition, Fixed Assets Acquired USD 4,000 2004-10-07 2013-12-31 2013 FY 20-F 2014-03-24 0001144204-14-017308
us-gaap NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1 Noncash or Part Noncash Acquisition, Value of Liabilities Assumed USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap NonoperatingIncomeExpense Nonoperating Income (Expense) USD 74,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NotesPayableCurrent Notes Payable, Current USD 81,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NumberOfOperatingSegments Number of Operating Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap NumberOfReportableSegments Number of Reportable Segments Integer 1 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OperatingExpenses Operating Expenses USD 15.76M 2026-01-01 2026-03-31 2026 Q1 10-Q 2026-05-19 0001493152-26-024446
us-gaap OperatingIncomeLoss Operating Income (Loss) USD -25.04M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OperatingLeaseCost Operating Lease, Cost USD 200,000 2024-01-01 2024-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023569
us-gaap OperatingLeaseImpairmentLoss Operating Lease, Impairment Loss USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeaseLiabilityCurrent Operating Lease, Liability, Current USD 4.60M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeaseLiabilityNoncurrent Operating Lease, Liability, Noncurrent USD 0 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeasePayments Operating Lease, Payments USD 177,111 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeaseRightOfUseAsset Operating Lease, Right-of-Use Asset USD 0 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeaseRightOfUseAssetAmortizationExpense Operating Lease, Right-of-Use Asset, Amortization Expense USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLeasesFutureMinimumPaymentsDue Operating Leases, Future Minimum Payments Due USD 1.31M 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesFutureMinimumPaymentsDueCurrent Operating Leases, Future Minimum Payments Due, Next Twelve Months USD 147,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesFutureMinimumPaymentsDueInFourYears Operating Leases, Future Minimum Payments, Due in Four Years USD 330,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesFutureMinimumPaymentsDueInThreeYears Operating Leases, Future Minimum Payments, Due in Three Years USD 313,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesFutureMinimumPaymentsDueInTwoYears Operating Leases, Future Minimum Payments, Due in Two Years USD 297,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesFutureMinimumPaymentsDueThereafter Operating Leases, Future Minimum Payments, Due Thereafter USD 225,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OperatingLeasesRentExpenseMinimumRentals Operating Leases, Rent Expense, Minimum Rentals USD 1.56M 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap OperatingLeasesRentExpenseNet Operating Leases, Rent Expense, Net USD 90,000 2021-01-01 2021-06-30 2021 Q2 6-K 2021-09-22 0001104659-21-118339
us-gaap OperatingLeaseWeightedAverageDiscountRatePercent Operating Lease, Weighted Average Discount Rate, Percent pure 0.1 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OperatingLossCarryforwards Operating Loss Carryforwards USD 4.90M 2024-12-31 2024 FY 10-K 2025-04-15 0000950170-25-054278
us-gaap OperatingLossCarryforwardsValuationAllowance Operating Loss Carryforwards, Valuation Allowance USD 300,000 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OtherAccruedLiabilitiesCurrent Other Accrued Liabilities, Current USD 980,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherAccruedLiabilitiesNoncurrent Other Accrued Liabilities, Noncurrent USD 560,150 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap OtherAssetsCurrent Other Assets, Current USD 107,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherAssetsNoncurrent Other Assets, Noncurrent USD 11,136 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, before Tax USD 81,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherComprehensiveIncomeLossNetOfTax Other Comprehensive Income (Loss), Net of Tax USD -3.99M 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent Other Comprehensive Income (Loss), Net of Tax, Portion Attributable to Parent USD 168,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherComprehensiveIncomeLossTax Other Comprehensive Income (Loss), Tax USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap OtherFinancialServicesCosts Other Financial Services Costs (Deprecated 2018-01-31) USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap OtherIntangibleAssetsNet Other Intangible Assets, Net USD 30.30M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherLiabilitiesCurrent Other Liabilities, Current USD 54,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherLiabilitiesNoncurrent Other Liabilities, Noncurrent USD 31,000 2025-12-31 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap OtherNonoperatingExpense Other Nonoperating Expense USD 3,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap OtherNonoperatingIncome Other Nonoperating Income USD 549,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap OtherNonoperatingIncomeExpense Other Nonoperating Income (Expense) USD -2,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap OtherPrepaidExpenseCurrent Other Prepaid Expense, Current USD 34,484 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OtherReceivablesNetCurrent Other Receivables, Net, Current USD 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap OtherRestrictedAssetsCurrent Other Restricted Assets, Current USD 142,000 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap PaymentsForProceedsFromInvestments Payments for (Proceeds from) Investments USD 600,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap PaymentsForRestructuring Payments for Restructuring USD 400,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap PaymentsOfStockIssuanceCosts Payments of Stock Issuance Costs USD 1.70M 2017-10-01 2017-10-20 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap PaymentsToAcquirePropertyPlantAndEquipment Payments to Acquire Property, Plant, and Equipment USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap PaymentsToAcquireRestrictedInvestments Payments to Acquire Restricted Investments USD 0 2015-01-01 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap PaymentsToAcquireShortTermInvestments Payments to Acquire Short-term Investments USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap PaymentsToFundLongtermLoansToRelatedParties Payments to Fund Long-term Loans to Related Parties USD 8,219 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001144204-16-089697
us-gaap PreferredStockParOrStatedValuePerShare Preferred Stock, Par or Stated Value Per Share USD/shares 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PreferredStockSharesAuthorized Preferred Stock, Shares Authorized shares 10.00M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PreferredStockSharesIssued Preferred Stock, Shares Issued shares 0 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap PreferredStockSharesOutstanding Preferred Stock, Shares Outstanding shares 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PreferredStockValue Preferred Stock, Value, Issued USD 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PrepaidExpenseAndOtherAssetsCurrent Prepaid Expense and Other Assets, Current USD 1.10M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PrepaidExpenseCurrent Prepaid Expense, Current USD 369,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap PrepaidInsurance Prepaid Insurance USD 489,093 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ProceedsFromContributionsFromAffiliates Proceeds from Contributions from Affiliates USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap ProceedsFromConvertibleDebt Proceeds from Convertible Debt USD 1.00M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap ProceedsFromIssuanceInitialPublicOffering Proceeds from Issuance Initial Public Offering USD 15.70M 2017-10-01 2017-10-20 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap ProceedsFromIssuanceOfCommonStock Proceeds from Issuance of Common Stock USD 1.09M 2025-01-01 2025-03-31 2026 Q1 10-Q 2026-05-19 0001493152-26-024446
us-gaap ProceedsFromIssuanceOfPrivatePlacement Proceeds from Issuance of Private Placement USD 69.60M 2015-09-01 2015-09-18 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised USD 33,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap ProceedsFromIssuanceOfWarrants Proceeds from Issuance of Warrants USD 1.04M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap ProceedsFromIssuanceOrSaleOfEquity Proceeds from Issuance or Sale of Equity USD 12.80M 2022-09-14 2023 FY 10-K 2024-03-29 0000950170-24-038661
us-gaap ProceedsFromNotesPayable Proceeds from Notes Payable USD 2.10M 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ProceedsFromOtherEquity Proceeds from Other Equity USD 33,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ProceedsFromPaymentsForLongTermLoansForRelatedParties Proceeds from Collection of (Payments to Fund) Long-term Loans to Related Parties USD 0 2018-01-01 2018-12-31 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap ProceedsFromRelatedPartyDebt Proceeds from Related Party Debt USD 250,000 2023-03-01 2023-03-31 8-K 2024-09-06 0000950170-24-104428
us-gaap ProceedsFromRepaymentsOfNotesPayable Proceeds from (Repayments of) Notes Payable USD -81,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments Proceeds from Sale, Maturity and Collection of Short-term Investments USD 0 2019-01-01 2019-12-31 2019 FY 20-F 2020-03-31 0001104659-20-040722
us-gaap ProceedsFromSaleOfPropertyPlantAndEquipment Proceeds from Sale of Property, Plant, and Equipment USD 66,500 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ProceedsFromStockOptionsExercised Proceeds from Stock Options Exercised USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ProceedsFromWarrantExercises Proceeds from Warrant Exercises USD 330,000 2025-01-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ProfitLoss Net Income (Loss), Including Portion Attributable to Noncontrolling Interest USD -2.08M 2024-04-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap PropertyPlantAndEquipmentGross Property, Plant and Equipment, Gross USD 752,892 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap PropertyPlantAndEquipmentNet Property, Plant and Equipment, Net USD 31,807 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap RelatedPartyTransactionAmountsOfTransaction Related Party Transaction, Amounts of Transaction USD 23,000 2016-01-01 2016-06-30 2016 Q2 6-K 2017-04-14 0001144204-17-020551
us-gaap RelatedPartyTransactionSellingGeneralAndAdministrativeExpensesFromTransactionsWithRelatedParty Related Party Transaction, Selling, General and Administrative Expenses from Transactions with Related Party USD 749,000 2014-01-01 2014-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap RepaymentsOfConvertibleDebt Repayments of Convertible Debt USD 700,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap RepaymentsOfDebt Repayments of Debt USD 553,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RepaymentsOfNotesPayable Repayments of Notes Payable USD 300,000 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap RepaymentsOfRelatedPartyDebt Repayments of Related Party Debt USD 0 2017-01-01 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap RepaymentsOfShortTermDebt Repayments of Short-term Debt USD 415,000 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ResearchAndDevelopmentExpense Research and Development Expense USD 5.64M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap RestrictedCash Restricted Cash USD 60,000 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap RestrictedCashAndCashEquivalents Restricted Cash and Cash Equivalents USD 5.80M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap RestrictedCashAndCashEquivalentsNoncurrent Restricted Cash and Cash Equivalents, Noncurrent USD 17,364 2019-06-30 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap RestrictedCashNoncurrent Restricted Cash, Noncurrent USD 60,000 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap RestructuringCharges Restructuring Charges USD -50,000 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RestructuringCosts Restructuring Costs USD 1.72M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RestructuringReserve Restructuring Reserve USD 450,000 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RestructuringReserveCurrent Restructuring Reserve, Current USD 450,000 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RestructuringReserveSettledWithoutCash2 Restructuring Reserve, Settled without Cash USD 285,000 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap RetainedEarningsAccumulatedDeficit Retained Earnings (Accumulated Deficit) USD -288.65M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap RevenueFromContractWithCustomerExcludingAssessedTax Revenue from Contract with Customer, Excluding Assessed Tax USD 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability Right-of-Use Asset Obtained in Exchange for Operating Lease Liability USD 0 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap SaleOfStockPricePerShare Sale of Stock, Price Per Share USD/shares 5 2017-10-20 2018 FY 20-F 2019-04-23 0001144204-19-020749
us-gaap SellingGeneralAndAdministrativeExpense Selling, General and Administrative Expense USD 7.26M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ShareBasedCompensation Share-based Payment Arrangement, Noncash Expense USD 1.55M 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period shares 1.60B 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 0.01 2022-01-01 2022-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number shares 21.48M 2022-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value USD/shares 0.01 2022-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate pure 0 2025-01-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023569
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate pure 1.114 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Maximum pure 0.832 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate, Minimum pure 0.707 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate pure 0.042 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Maximum pure 0.013 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate, Minimum pure 0.006 2021-01-01 2021-12-31 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value USD 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number shares 1.36M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price USD/shares 6.46 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Expirations in Period shares 137,300 2013-01-01 2013-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures in Period shares 335,646 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross shares 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value USD/shares 1.09 2012-01-01 2012-12-31 2012 FY 20-F/A 2013-04-19 0001144204-13-022773
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value USD 0 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number shares 1.36M 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price USD/shares 6.46 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value USD 0 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number shares 2.70M 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price USD/shares 1.47 2015-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1 Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested in Period, Fair Value USD 26.00M 2015-01-01 2015-12-31 2015 FY 10-K 2016-03-23 0001144204-16-089697
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Number of Shares shares 5,500 2026-01-01 2026-06-30 2026 Q2 10-Q 2026-08-13 0001493152-26-037730
us-gaap SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested, Weighted Average Grant Date Fair Value USD/shares 10.2 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ShareBasedCompensationArrangementByShareBasedPaymentAwardSharesPurchasedForAward Share-based Compensation Arrangement by Share-based Payment Award, Shares Purchased for Award shares 5.81M 2018-01-01 2018-06-30 2018 Q2 6-K 2018-09-27 0001144204-18-050995
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Expirations in Period, Weighted Average Exercise Price USD/shares 1.51 2013-01-01 2013-12-31 2014 FY 10-K 2015-02-11 0001144204-15-007770
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Forfeitures in Period, Weighted Average Exercise Price USD/shares 0.51 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price USD/shares 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap SharePrice Share Price USD/shares 10.115 2022-12-29 8-K 2024-09-06 0000950170-24-104428
us-gaap SharesIssuedPricePerShare Shares Issued, Price Per Share USD/shares 0.6 2014-06-30 2015 Q2 10-Q 2015-08-12 0001144204-15-048274
us-gaap ShortTermBorrowings Short-term Debt USD 200,000 2024-09-30 2024 Q3 10-Q 2024-11-19 0000950170-24-128727
us-gaap ShortTermDebtPercentageBearingFixedInterestRate Short-term Debt, Percentage Bearing Fixed Interest Rate pure 0.075 2024-02-29 2024 Q3 10-Q 2024-11-19 0000950170-24-128727
us-gaap ShortTermInvestments Short-term Investments USD 0 2017-12-31 2017 FY 20-F 2018-07-18 0001144204-18-038891
us-gaap StockholdersEquity Stockholders' Equity Attributable to Parent USD 17.50M 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssued1 Stock Issued USD 1.00M 2025-01-01 2025-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities Stock Issued During Period, Shares, Conversion of Convertible Securities shares 10 2017-06-01 2017-06-26 2017 Q2 6-K 2017-08-10 0001144204-17-042102
us-gaap StockIssuedDuringPeriodSharesNewIssues Stock Issued During Period, Shares, New Issues shares 7.95M 2021-07-07 2022 Q2 6-K 2022-09-27 0001410578-22-002815
us-gaap StockIssuedDuringPeriodSharesRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Shares, Restricted Stock Award, Net of Forfeitures shares 125,911 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap StockIssuedDuringPeriodSharesStockOptionsExercised Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period shares 0 2024-01-01 2024-06-30 8-K 2024-09-06 0000950170-24-104428
us-gaap StockIssuedDuringPeriodValueAcquisitions Stock Issued During Period, Value, Acquisitions USD 28.13M 2024-01-01 2024-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap StockIssuedDuringPeriodValueConversionOfConvertibleSecurities Stock Issued During Period, Value, Conversion of Convertible Securities USD 192,000 2025-07-01 2025-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValueConversionOfUnits Stock Issued During Period, Value, Conversion of Units USD 309,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValueEmployeeBenefitPlan Stock Issued During Period, Value, Employee Benefit Plan USD 0 2018-01-01 2018-12-31 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap StockIssuedDuringPeriodValueIssuedForServices Stock Issued During Period, Value, Issued for Services USD 2.91M 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValueNewIssues Stock Issued During Period, Value, New Issues USD 5.20M 2026-04-01 2026-06-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValueOther Stock Issued During Period, Value, Other USD 223,000 2026-07-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValuePurchaseOfAssets Stock Issued During Period, Value, Purchase of Assets USD 105,317 2023-01-01 2023-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardGross Stock Issued During Period, Value, Restricted Stock Award, Gross USD 33,000 2025-04-01 2025-06-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap StockIssuedDuringPeriodValueRestrictedStockAwardNetOfForfeitures Stock Issued During Period, Value, Restricted Stock Award, Net of Forfeitures USD 3,000 2024-01-01 2024-03-31 2025 Q1 10-Q 2025-05-14 0000950170-25-071563
us-gaap StockIssuedDuringPeriodValueShareBasedCompensation Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture USD 33,000 2025-04-01 2025-06-30 2025 Q2 10-Q 2025-08-13 0001641172-25-023569
us-gaap StockIssuedDuringPeriodValueShareBasedCompensationGross Shares Issued, Value, Share-based Payment Arrangement, before Forfeiture USD 76,000 2015-01-01 2015-09-30 2015 Q3 10-Q 2015-11-23 0001144204-15-067423
us-gaap StockIssuedDuringPeriodValueStockOptionsExercised Stock Issued During Period, Value, Stock Options Exercised USD 27,500 2020-01-01 2020-12-31 2022 FY 20-F 2023-05-01 0001410578-23-000848
us-gaap StockOptionPlanExpense Stock or Unit Option Plan Expense USD 3,000 2011-01-01 2011-12-31 2012 FY 20-F/A 2013-04-19 0001144204-13-022773
us-gaap StockRepurchasedAndRetiredDuringPeriodShares Stock Repurchased and Retired During Period, Shares shares 375,939 2022-12-29 8-K 2024-09-06 0000950170-24-104428
us-gaap StockRepurchasedAndRetiredDuringPeriodValue Stock Repurchased and Retired During Period, Value USD 3.80M 2022-01-01 2022-12-31 8-K 2024-09-06 0000950170-24-104428
us-gaap StockRepurchasedDuringPeriodShares Stock Repurchased During Period, Shares shares 375,939 2022-12-29 8-K 2024-09-06 0000950170-24-104428
us-gaap StockRepurchasedDuringPeriodValue Stock Repurchased During Period, Value USD 0 2014-01-01 2014-12-31 2016 FY 20-F 2017-03-31 0001144204-17-018167
us-gaap TaxesOther Taxes, Other USD 22,825 2023-01-01 2023-06-30 2023 Q2 6-K 2023-09-29 0001410578-23-002132
us-gaap UnrecognizedTaxBenefits Unrecognized Tax Benefits USD 0 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap ValuationAllowanceDeferredTaxAssetChangeInAmount Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount USD 3.00M 2025-01-01 2025-12-31 2025 FY 10-K 2026-03-30 0001493152-26-013664
us-gaap ValueAddedTaxReceivableCurrent Value Added Tax Receivable, Current USD 2.90M 2019-09-30 2020 FY 20-F 2021-04-21 0001104659-21-052672
us-gaap WarrantsAndRightsOutstanding Warrants and Rights Outstanding USD 3.20M 2020-12-08 2021 FY 20-F 2022-05-16 0001410578-22-001546
us-gaap WeightedAverageNumberOfDilutedSharesOutstanding Weighted Average Number of Shares Outstanding, Diluted shares 176.32B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372
us-gaap WeightedAverageNumberOfShareOutstandingBasicAndDiluted Weighted Average Number of Shares Outstanding, Basic and Diluted shares 3.87B 2021-01-01 2021-06-30 2021 Q2 6-K 2021-09-22 0001104659-21-118339
us-gaap WeightedAverageNumberOfSharesOutstandingBasic Weighted Average Number of Shares Outstanding, Basic shares 176.32B 2026-01-01 2026-09-30 2026 Q3 10-Q 2026-11-12 0001493152-26-051372

Financialist News Desk

Our desk turns official SEC filings into news. Each story is checked against the original filing. About us → · Editorial standards →